Synthesis and Antimalarial activity of 3,3-spiroanellated 5,6-disubstituted-1,2,4-trioxanes

Show simple item record

dc.contributor.author Maurya, Ranjani
dc.contributor.author Soni, Awakash
dc.contributor.author Anand, Devireddy
dc.contributor.author Ravi, Makthala
dc.contributor.author Raju, K S R
dc.contributor.author Taneja, Isha
dc.contributor.author Naikade, N K
dc.contributor.author Puri, S K
dc.contributor.author Wahajuddin
dc.contributor.author Kanojiya, Sanjeev
dc.contributor.author Yadav, P P
dc.date.accessioned 2013-03-06T06:27:38Z
dc.date.available 2013-03-06T06:27:38Z
dc.date.issued 2013
dc.identifier.citation ACS Medicinal Chemistry Letters, 2013, 4 (2), 165–169 en
dc.identifier.uri http://hdl.handle.net/123456789/1008
dc.description.abstract Novel 3,3-spiroanellated 5-aryl, 6-arylvinyl substituted 1,2,4-trioxanes 19-34 have been syn-thesized and appraised for their antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in swiss mice by oral route at the doses ranging from 96 mg/kg x 4 days to 24 mg/kg x 4 days. 1,2,4-trioxane 25 the most active compounds of the series, provided 100% protection at 24 mg/kg x 4 days and other 1,2,4-trioxanes 22, 26, 27 and 30 also showed promising activity. In this model β-arteether provided 100% and 20% protection at 48 mg/kg x 4 days and 24 mg/kg x 4 days, respectively by oral route. en
dc.format.extent 232406 bytes
dc.format.mimetype application/pdf
dc.language.iso en en
dc.relation.ispartofseries CDRI communication no. 8341 en
dc.subject 1,2,4-trioxane en
dc.subject Antimalarial en
dc.subject In-vivo en
dc.subject Orally active en
dc.title Synthesis and Antimalarial activity of 3,3-spiroanellated 5,6-disubstituted-1,2,4-trioxanes en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account